Clinical Trial Update: The Effect of Ganglion Sphenopalatine Block (GSP-block) Versus Placebo on Postdural Puncture Headache [Phase 3]

View source ↗

Summary

Phase 3 trial comparing ganglion sphenopalatine block to placebo for postdural puncture headache has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postdural Puncture Headache

Drugs mentioned

• Ganglion sphenopalatine block (GSP-block)

Snippet

Sponsor: University Hospital Bispebjerg and Frederiksberg | Conditions: Postdural Puncture Headache, Sphenopalatine Ganglion Block | Phase 3 | Status: COMPLETED